Looking to collaborate?
What does your test detect?
What infection type does your test focus on?
What is the technological basis of your test?
About this entry
OmiX Labs is developing a molecular diagnostic platform and AMR signature assays that can be used to detect susceptibility to existing and repurposed antibiotics. Using OmiX's proprietary amplification technology, a culture free rapid test is being developed for detection of genes to identify the organisms and predict susceptibility.